New stent design may spare men's sex life after stone removal
NCT ID NCT07415993
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 96 men who needed a temporary tube (stent) in their ureter after kidney stone surgery. Half got a standard stent, the other half got a new anti-reflux stent. Researchers checked sexual function, mood, and hormone levels over 8 weeks to see if the anti-reflux design causes fewer sexual side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
96 people
The number who actually took part.
- Started
-
Jun 2020
- Finished
-
Mar 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * male sexually active patients with unilateral ureteral calculi who underwent ureteroscopy with laser lithotripsy and needed post-procedure stent Exclusion Criteria: * Patients were excluded if they included the following criteria: (1) age under 18 or over 50 years, (2) history of previous ureteral stenting, (3) bilateral stents, (4) moderate or severe ureteral stricture need long-term stenting (on regular exchange), (5) bladder pathology and overactive bladder, (6) symptomatic benign prostatic hyperplasia, (7) moderate or severe urinary tract infection, (8) moderate or severe cardiovascular disease, hepatic dysfunction and diabetes, (9) previous use of selective alpha-1-blocker and/or antimuscarinic agent, (10) pre-op IIEF-5 ≤ 21.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Male sexual function are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jintan Affiliated Hospital of Jiangsu University
Changzhou, Jiangsu, 213000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Shock waves vs. scope: a Head-to-Head battle for kidney stone relief
- World's largest kidney stone surgery study launches
- Can an amino acid help pass kidney stones better than a standard drug?
- Bladder drug may save kids from second surgery for kidney stones
- New stent aims to make kidney stone recovery less painful
- Sleep aid and bladder drug tested to ease stent discomfort